Compensated hepatitis C: Unenhanced MR imaging correlated with pathologic grading and staging

Abdominal Imaging

Volumn 33, Issue 1, 2008, Pages 58-64

  Mitchell, Donald G ^a,c   Navarro, Victor J ^b   Herrine, Steven K ^b   Bergin, Diane ^a   Parker, Laurence ^a   Frangos, Andrea ^a   McCue, Peter ^a   Rubin, Raphael ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

Cirrhosis; Hepatitis; Liver; MRI

Indexed keywords

ANTIVIRUS AGENT;

ADULT; AGED; ANTIVIRAL THERAPY; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; FATTY LIVER; FEMALE; GALLBLADDER; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PRIORITY JOURNAL;

ADULT; AGED; BIOPSY; FATTY LIVER; FEMALE; FIBROSIS; HEPATITIS C, CHRONIC; HUMANS; INFLAMMATION; LIVER FUNCTION TESTS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES; REGRESSION ANALYSIS;

EID: 37549047579     PISSN: 09428925     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00261-007-9203-7     Document Type: Article

References (38)

1. Armstrong GL, Wasley A, Simard EP, et al. (2006) The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 144:705-714
2. Lauer GM, Walker BD, Hepatitis C (2001) virus infection. N Engl J Med 345:41-52
3. DiBisceglie AM, Thompson J, Smith-Wilkaitis N, et al. (2001) Combination of interferon and ribavirin in chronic hepatitis C: re-treatment of nonre-sponders to interferon. Hepatology 33:704-707
4. Kisloff B (2001) Periodic liver biopsy for mild hepatitis C. Ann Intern Med 135:381-382
5. Brunt EM (2000) Grading and staging the histopathological lesions of chronic hepatitis: the Knodell histology activity index and beyond. Hepatology 31:241-246
6. Kirn AI, Saab S (2005) Treatment of hepatitis C. Am J Med 18:808-815
7. Strader DB, Wright T, Thomas DL et al. (2004) Diagnosis, management, and treatment of hepatitis C. Hepatology 39:1147-1171
8. Herrine SK (2002) Approach to the patient with chronic hepatitis C virus infection. Ann Intern Med 136:747-757
9. Farrell RJ, Smiddy PF, Pilkington RM, et al. (1999) Guided versus blind liver biopsy for chronic hepatitis C: clinical benefits and costs. J Hepatol 30:580-587
10. Maharaj B, Bhoora IG (1992) Complications associated with percutaneous needle biopsy of the liver when one, two or three specimens are taken. Postgrad Med J 68:964-967
11. Janes CH, Lindor KD (1993) Outcome of patients hospitalized for complications after outpatient liver biopsy. Ann Intern Med 18:96-98
12. Alberti A, Noventa F, Benvegnu L, Boccato S, Gatta A (2002) Prevalence of liver disease in a population of asymptomatic persons with hepatitis C virus infection. Ann Intern Med 137:961-964
13. Chuah SY, Moody GA, Wicks AC, et al. (1994) A nationwide survey of liver biopsy-is there a need to increase resources, manpower and training? Hepatogastroenterology 41:4-8
14. Regev A, Berho M, Jeffers LJ, et al. (2002) Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 97:2614-2618
15. Bedossa P, Dargere D, Paradis V (2003) Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 38:1449-1457
16. Taouli B, Losada M, Holland A, et al. (2004) Magnetic resonance imaging of hepato-cellular carcinoma. Gastroenterology 127:S144-152
17. Murakami T, Mochizuki K, Nakamura H (2001) Imaging evaluation of the cirrhotic liver. Semin Liver Dis 21:213-224
18. Semelka RC, Chung JJ, Hussain SM, Marcos HB, Woosley JT (2001) Chronic hepatitis: correlation of early patchy and late linear enhancement patterns on gadolinium-enhanced MR images with histopathology initial experience. J Magn Reson Imaging 13:385-391
19. Aguirre DA, Behling CA, Alpert E, Hassanein TI, Sirlin CB (2006) Liver fibrosis: noninvasive diagnosis with double contrast material-enhanced MR imaging. Radiology 239:425-437
20. Cho SG, Kirn MY, Kirn HJ, et al. (2001) Chronic hepatitis: in vivo proton MR spectroscopic evaluation of the liver and correlation with histopathologic findings. Radiology 221:740-746
21. Koinuma M, Ohashi I, Hanafusa K, et al. (2005) Apparent diffusion coefficient measurements with diffusion-weighted magnetic resonance imaging for evaluation of hepatic fibrosis. J Magn Reson Imaging 22:80-85
22. Pandharipande PV, Krinsky GA, Rusinek H, et al. (2005) Perfusion imaging of the liver: current challenges and future goals. Radiology 234:661-673
23. Lafortune M, Matricardi L, Denys A, et al. (1998) Segment 4 (the quadrate lobe): a barometer of cirrhotic liver disease at US. Radiology 206:157-160
24. Harbin WP, Robert NJ, Ferrucci JT (1980) Diagnosis of cirrhosis based on regional changes in hepatic morphology: a radiological and pathological analysis. Radiology 135:273-283
25. Mitchell DG, Lovett KE, Hann HW, et al. (1993) Cirrhosis: multiobserver analysis of hepatic MR imaging findings in a heterogeneous population. J Magn Reson Imaging 3:313-321
26. Awaya H, Mitchell DG, Kamishima T, et al. (2002) Cirrhosis: modified caudate-right lobe ratio. Radiology 224:769-774
27. Ito K, Mitchell DG, Gabata T, et al. (1999) Expanded gallbladder fossa: simple MR imaging sign of cirrhosis. Radiology 211:723-726
28. Ito K, Mitchell DG, Gabata T (2000) Enlargement of hilar periportal space: a sign of early cirrhosis at MR imaging. J Magn Reson Imaging 11:136-140
29. Choi MS, Lee JH, Koh KC, et al (2001) Clinical significance of enlarged perihepatic lymph nodes in chronic hepatitis B. J Clin Gastroenterol 32:329-332
30. Dietrich CF, Lee JH, Herrmann G et al. (1997) Enlargement of perihepatic lymph nodes in relation to liver histology and viremia in patients with chronic hepatitis C. Hepatology 26:467-472
31. Soresi M, Carroccio A, Agate V, et al. (1999) Evaluation by ultrasound of abdominal lymphadenopathy in chronic hepatitis C. Am J Gastroenterol 94:497-501
32. Wedemeyer H, Ockenga J, Frank H, et al. (1998) Perihepatic lymphadenopathy: a marker of response to interferon alpha in chronic hepatitis C. Hepatogastroenterology 45:1062-1068
33. Zhang XM, Mitchell DG, Shi H, et al. (2002) Chronic hepatitis C activity: correlation with lymphadenopathy on MR imaging. AJR Am J Roentgenol 179:417-422
34. Ishak K, Baptista A, Bianchi, L et al. (1995) Histological grading and staging of chronic hepatitis. J Hepatol 22:696-699
35. Lefkowitch JH, Schiff ER, Davis GL, et al. (1993) Pathological diagnosis of chronic hepatitis C: a multicenter comparative study with chronic hepatitis B. The Hepatitis Interventional Therapy Group. Gastroenterology 104:595-603
36. Leandro G, Mangia A, Hui J, et al. (2006) Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data. Gastroenterology l30:l636-l642
37. Mitchell DG, Crovello M, Matteucci T, et al. (1992) Benign adreno-cortical masses: diagnosis with chemical shift MR imaging. Radiology 185:345-351
38. Mitchell DG, Kim I, Chang TS, et al. (1991) Fatty liver: chemical shift saturation and phase-difference MR imaging techniques in animals, phantoms and humans. Invest Radiol 26:1041-1052